About Myocyte-specific enhancer factor 2B
Myocyte-specific enhancer factor 2B (MEF2B) is a protein
from Homo sapiens identified by UniProt accession
Q02080, 365 residues long.
MolForge cross-references it against 0 known binders and
63 disease associations.
Target properties
| Protein name | Myocyte-specific enhancer factor 2B |
| UniProt accession | Q02080 |
| Gene | MEF2B |
| Organism | Homo sapiens |
| Length | 365 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (63)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.52
- diffuse large B-cell lymphoma · score 0.49
- lymphoma · score 0.37
- non-Hodgkins lymphoma · score 0.37
- lysosomal storage disease · score 0.31
- mean arterial pressure · score 0.27
- diastolic blood pressure · score 0.27
- obsessive-compulsive symptom measurement · score 0.24
- total blood protein measurement · score 0.23
- triglyceride measurement · score 0.22
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q02080-F1 | alphafold | PREDICTED | 60.77 | — |
Amino-acid sequence (365 residues)
MGRKKIQISR ILDQRNRQVT FTKRKFGLMK KAYELSVLCD CEIALIIFNS ANRLFQYAST DMDRVLLKYT EYSEPHESRT NTDILETLKR RGIGLDGPEL EPDEGPEEPG EKFRRLAGEG GDPALPRPRL YPAAPAMPSP DVVYGALPPP GCDPSGLGEA LPAQSRPSPF RPAAPKAGPP GLVHPLFSPS HLTSKTPPPL YLPTEGRRSD LPGGLAGPRG GLNTSRSLYS GLQNPCSTAT PGPPLGSFPF LPGGPPVGAE AWARRVPQPA APPRRPPQSA SSLSASLRPP GAPATFLRPS PIPCSSPGPW QSLCGLGPPC AGCPWPTAGP GRRSPGGTSP ERSPGTARAR GDPTSLQASS EKTQQ
Explore Myocyte-specific enhancer factor 2B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets